Effect of vitamin D on the improvement of infants and children with congenital heart disease
Phase 3
Recruiting
- Conditions
- congenital heart disease.Congenital malformation of heart, unspecified
- Registration Number
- IRCT20170316033099N6
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Suffering from congenital heart disease
Risk adjustment for congenital heart surgery score below 5
Age below or equal to 18 years
Serum vitamin D level below or equal to 150 nanograms per milliliter
Consent from parent or legal guardian to participate in the study
The patient being candidate for open heart surgery
Exclusion Criteria
Being treated with steroidal drugs
Vitamin D contraindications
Application of cardio-respiratory support device
Contraindications for oral medication
Active cardiopulmonary resuscitation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vasoactive-Inotrope Score. Timepoint: 24 and 48 hours postoperatively. Method of measurement: Vasoactive-Inotrope Score calculation formula.;Vasoactive-Inotrope Score. Timepoint: 24 and 48 hours postoperatively. Method of measurement: Inotrope Score calculation formula.
- Secondary Outcome Measures
Name Time Method